Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

August 18, 2022 01:02:07
Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update
MitoAction Expert Series
Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

Aug 18 2022 | 01:02:07

/

Show Notes

There was much discussion about current research in FAODs at our recent International Metabolic conference last month. Reneo Pharmaceuticals recently released positive results from the REN001 Phase1b LC-FAOD Study.

Other Episodes

Episode 0

February 14, 2021 00:44:59
Episode Cover

Patients as Partners in Drug Development - Dr. Madhu Davies - 2/12/21

Join MitoAction and Dr. Madhu Davies from Reneo Pharmaceuticals for our February Monthly Mito Expert Series titled “Patients as Partners in Drug Development.” About...

Listen

Episode

June 24, 2022 01:06:36
Episode Cover

What You Should Know About Genetic Testing for Mitochondrial Disorders

Join Amanda Balog, CGC, Senior Genetic Counselor, Mitochondrial and Metabolic Genetics, of GeneDx as she discusses: "What You Should Know About Genetic Testing for...

Listen

Episode 0

June 08, 2020 01:08:50
Episode Cover

FAOD: The Other Mitochondrial Energy Diseases - Dr. Jerry Vockley - 10/4/19

About the Speaker Dr. Vockley received his undergraduate degree at Carnegie-Mellon University in Pittsburgh, Pennsylvania, and received his degree in Medicine and Genetics from...

Listen